Amneal Pharmaceuticals Inc. Class A Common Stock (AMRX) Stock Price Today
CIQ launches Fuzzball 4.3 for easy AI model deployment on existing GPU infrastructure
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
Canadian Utilities to merge with Emera, RBC Capital keeps 'Sector Perform' rating
Canadian Utilities and Emera have agreed to merge as equals, creating a larger utility and energy infrastructure company. RBC Capital maintains a 'Sector Perform' rating on Canadian Utilities, indicating expected performance in line with the sector. ...
Resilinc launches Microsoft Copilot plugin for real-time, organization-specific supply chain risk and compliance insights.
Resilinc introduced a new plugin for Microsoft Copilot that allows authorized enterprise users to access live, organization-specific supply chain risk and compliance intelligence directly within Microsoft applications. This integration helps teams qu...
AI boosts lithium battery industry efficiency and investment across mining, manufacturing, and recycling sectors.
AI is transforming the lithium battery value chain by speeding up development, improving manufacturing yields, optimizing resource recovery, and enabling smarter recycling. Significant investments are flowing into AI-driven projects, including $2.2 b...
RBC Capital raises Amgen price target to $430 amid strong stock performance and upcoming earnings.
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting confidence in the biotechnology company's recent strong stock performance. Amgen's shares have outperformed the broader market and its sector, rising 2.6% recently whi...
Global Mivan construction market to grow to $7.05B by 2031, driven by mass housing and automation.
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
RBC Capital raises Amgen price target to $430 on strong earnings outlook
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray misses Q1 earnings estimates despite revenue growth, cuts debt, and maintains 2027 EBITDA forecast.
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group Q3 earnings preview: $4.12 EPS expected, focus on Medicare Advantage trends and medical costs.
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
Fieldstone Bio joins Rio Tinto accelerator to advance biosensor tech for faster mineral exploration.
Fieldstone Bio, a synthetic biology company, was selected for the Mining Tech Accelerator program by Founders Factory and Rio Tinto. The program supports innovative technologies that improve mineral exploration and extraction, providing Fieldstone wi...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.